BR112021017720A2 - Sistemas e métodos para tratamento de distúrbios respiratórios do sono - Google Patents

Sistemas e métodos para tratamento de distúrbios respiratórios do sono

Info

Publication number
BR112021017720A2
BR112021017720A2 BR112021017720A BR112021017720A BR112021017720A2 BR 112021017720 A2 BR112021017720 A2 BR 112021017720A2 BR 112021017720 A BR112021017720 A BR 112021017720A BR 112021017720 A BR112021017720 A BR 112021017720A BR 112021017720 A2 BR112021017720 A2 BR 112021017720A2
Authority
BR
Brazil
Prior art keywords
systems
methods
disordered breathing
treating sleep
root
Prior art date
Application number
BR112021017720A
Other languages
English (en)
Inventor
David Kent
Original Assignee
Univ Vanderbilt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Vanderbilt filed Critical Univ Vanderbilt
Publication of BR112021017720A2 publication Critical patent/BR112021017720A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
    • A61N1/3611—Respiration control
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
    • A61N1/36078—Inducing or controlling sleep or relaxation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/56—Devices for preventing snoring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0551—Spinal or peripheral nerve electrodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/36128—Control systems
    • A61N1/36135—Control systems using physiological parameters
    • A61N1/36139—Control systems using physiological parameters with automatic adjustment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0502—Skin piercing electrodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0551—Spinal or peripheral nerve electrodes
    • A61N1/0556—Cuff electrodes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Nursing (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Electrotherapy Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

sistemas e métodos para tratamento de distúrbios respiratórios do sono. métodos e sistemas de tratamento de distúrbios respiratórios do sono em um paciente que sofre dos mesmos, ativando um ou mais músculos infra-hióideos, são fornecidos. a ativação de um ou mais músculos infra-hióideos pode ser realizada estimulando uma ansa cervicalis, incluindo uma ou ambas da raiz superior e a raiz inferior da ansa cervicalis, isoladamente ou em combinação com a estimulação do nervo hipoglosso.
BR112021017720A 2019-03-08 2020-03-06 Sistemas e métodos para tratamento de distúrbios respiratórios do sono BR112021017720A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962815393P 2019-03-08 2019-03-08
US201962843641P 2019-05-06 2019-05-06
PCT/US2020/021359 WO2020185549A1 (en) 2019-03-08 2020-03-06 Systems and methods for treating sleep disordered breathing

Publications (1)

Publication Number Publication Date
BR112021017720A2 true BR112021017720A2 (pt) 2021-11-16

Family

ID=72427070

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021017720A BR112021017720A2 (pt) 2019-03-08 2020-03-06 Sistemas e métodos para tratamento de distúrbios respiratórios do sono

Country Status (10)

Country Link
US (1) US20220032052A1 (pt)
EP (1) EP3846896A4 (pt)
JP (1) JP7482590B2 (pt)
CN (1) CN113660975A (pt)
AU (2) AU2020233880B2 (pt)
BR (1) BR112021017720A2 (pt)
CA (1) CA3132722C (pt)
IL (1) IL286134A (pt)
MX (1) MX2021010788A (pt)
WO (1) WO2020185549A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11247039B2 (en) 2016-05-03 2022-02-15 Btl Healthcare Technologies A.S. Device including RF source of energy and vacuum system
US10583287B2 (en) 2016-05-23 2020-03-10 Btl Medical Technologies S.R.O. Systems and methods for tissue treatment
US10556122B1 (en) 2016-07-01 2020-02-11 Btl Medical Technologies S.R.O. Aesthetic method of biological structure treatment by magnetic field
WO2021076662A1 (en) 2019-10-16 2021-04-22 Invicta Medical, Inc. Adjustable devices for treating sleep apnea, and associated systems and methods
US11878167B2 (en) 2020-05-04 2024-01-23 Btl Healthcare Technologies A.S. Device and method for unattended treatment of a patient
JP2023515722A (ja) 2020-05-04 2023-04-13 ビーティーエル ヘルスケア テクノロジーズ エー．エス． 患者の非アテンド式治療のためのデバイスおよび方法
US20220134101A1 (en) 2020-10-30 2022-05-05 Medtronic Xomed, Inc. Sleep apnea therapy
JP2023548970A (ja) 2020-11-04 2023-11-21 インヴィクタ メディカル インコーポレイテッド 睡眠時無呼吸を治療するための遠隔給電式植え込み型電極並びに関連システム及び方法
US11896816B2 (en) 2021-11-03 2024-02-13 Btl Healthcare Technologies A.S. Device and method for unattended treatment of a patient
WO2024006529A1 (en) * 2022-06-30 2024-01-04 Vanderbilt University Systems and methods of improving sleep disordered breathing

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5591216A (en) * 1995-05-19 1997-01-07 Medtronic, Inc. Method for treatment of sleep apnea by electrical stimulation
US7280873B2 (en) * 1995-10-27 2007-10-09 Esd, Llc Treatment of oropharyngeal disorders by application of neuromuscular electrical stimulation
AU1093099A (en) * 1997-10-17 1999-05-10 Penn State Research Foundation; The Muscle stimulating device and method for diagnosing and treating a breathin g disorder
US6928324B2 (en) * 2002-02-14 2005-08-09 Pacesetter, Inc. Stimulation device for sleep apnea prevention, detection and treatment
JP2007525277A (ja) * 2004-02-26 2007-09-06 サンダーズ，アイラ 閉塞型睡眠時無呼吸といびきの治療法と装置
US7650189B1 (en) * 2006-06-02 2010-01-19 Pacesetter, Inc. Techniques to maintain or alter upper airway patency
CA2666529A1 (en) * 2006-10-13 2008-04-24 Apnex Medical, Inc. Obstructive sleep apnea treatment devices, systems and methods
EP2331201B1 (en) * 2008-10-01 2020-04-29 Inspire Medical Systems, Inc. System for treating sleep apnea transvenously
CA2780096A1 (en) * 2009-11-10 2011-05-19 Imthera Medical, Inc. System for stimulating a hypoglossal nerve for controlling the position of a patient's tongue
US8983610B2 (en) * 2009-11-18 2015-03-17 Case Western Reserve University Hybrid method for modulating upper airway function in a subject
US9254219B2 (en) * 2012-06-01 2016-02-09 Totada R. Shantha Snoring and obstructive sleep apnea prevention and treatment device
AU2020345951B2 (en) * 2019-09-13 2024-01-04 Vanderbilt University Neuromodulation of the glossopharyngeal nerve to improve sleep disordered breathing

Also Published As

Publication number Publication date
EP3846896A1 (en) 2021-07-14
AU2020233880A1 (en) 2021-10-07
AU2023202435A1 (en) 2023-05-11
CA3132722C (en) 2024-01-16
AU2020233880B2 (en) 2023-04-27
MX2021010788A (es) 2022-01-18
EP3846896A4 (en) 2022-06-01
JP2022524115A (ja) 2022-04-27
CN113660975A (zh) 2021-11-16
IL286134A (en) 2021-10-31
WO2020185549A1 (en) 2020-09-17
US20220032052A1 (en) 2022-02-03
JP7482590B2 (ja) 2024-05-14
CA3132722A1 (en) 2020-09-17

Similar Documents

Publication Publication Date Title
BR112021017720A2 (pt) Sistemas e métodos para tratamento de distúrbios respiratórios do sono
BR112013000027A2 (pt) tratamento de distúrbios cognitivos
Nuyts et al. Reduction of the dose to the elective neck in head and neck squamous cell carcinoma, a randomized clinical trial using intensity modulated radiotherapy (IMRT). Dosimetrical analysis and effect on acute toxicity
EP3857916A4 (en) AURICULAR NERVE STIMULATION FOR THE TREATMENT OF PATIENT DISORDERS AND RELATED SYSTEMS AND PROCEDURES
EP4252833A3 (en) Microstimulation sleep disordered breathing (sdb) therapy device
BR112018068906A2 (pt) composição, método, método de redução de risco, prevenção ou tratamento de um indivíduo que tem uma doença ou distúrbio autoimune, método de indução de degradação de uma proteína-alvo numa célula, método para reduzir o risco, prevenir ou tratar um estado da doença ou afecção num paciente em que a atividade proteica desregulada é responsável pelo referido estado da doença ou afecção, método para reduzir o risco, prevenir ou tratar câncer num indivíduo e método de tratamento de uma doença ou distúrbio genético num indivíduo
CY1116344T1 (el) Κυτταρα προερχομενα απο ιστο ομφαλιου λωρου για την θεραπεια νευροπαθητικου πονου και σπαστικοτητας
EP4299106A3 (en) Accessing spinal network to enable respiratory function
BR112015027282A8 (pt) formulação líquida e kit compreendendo fenfluramina, e usos da mesma no tratamento de síndrome de dravet
WO2010002936A3 (en) Systems, methods and devices for paired plasticity
WO2019006005A3 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF MELANOMA
SG10201902664RA (en) Combination therapy for treating cancer
WO2010028152A3 (en) Systems, devices and methods for the treatment of tinnitus
MY202377A (en) Treating gastric cancer using combination therapies comprising liposomal irinotecan, oxaliplatin, 5-fluorouracil (and leucovorin)
WO2017160781A3 (en) Devices for delivering a chemical denervation agent and methods of use
NO20064192L (no) Agonister og antagonister av P28, EB13 og WSX/TCCR til behandling av immunforstyrrelser
WO2019067405A3 (en) FORMULATION OF FENFLURAMINE COMPATIBLE WITH A CÉTOGENEOUS REGIMEN
BR112012010786A2 (pt) udo de derivados de benzo-heterociclo para medir e tratar câncer ou para inibir metástase de câncer
BR112018073037A2 (pt) métodos para tratar um distúrbio do ritmo sono-vigília irregular e pelo menos um distúrbio do sono do ritmo circadiano, para melhorar continuidade do sono noturno, comportamentos e dificuldades cognitivas e pelo menos uma dificuldade comportamental e/ou cognitiva, para tratar sonolência e/ou cochilos diurnos excessivos, e, para estabilizar e para melhorar um ou mais ritmos circadianos.
MX2021010058A (es) Formulaciones de rapamicina tópicas y su uso en el tratamiento de angiofibromas faciales y otros trastornos de la piel.
BR112015023439A2 (pt) combinação de tratamentos de câncer utilizando micrornas e inibidores egfr-tki
BR112019022908A2 (pt) Micropartícula de agregação sólida, sólido liofilizado ou reconstituível de micropartículas de agregação, método para tratamento de um distúrbio ocular, e, uso das micropartículas de agregação sólidas
EP3712264A8 (en) Cystathionine beta-synthase enzyme for treatment of homocystinuria
BR112014023572A2 (pt) método para tratar ou prevenir dano de articulação em um indivíduo com ra precoce ou ra incipiente, uso de um agente ou combinação de agentes que estimulam uma resposta tolerogênica específica de antígeno a um polipeptídeo de agrecan, e agente ou combinação de agentes
WO2019157495A3 (en) Methods for preventing and/or treating bone loss conditions by modulating irisin